Organon & Co. (OGN)
PHARMACEUTICAL PREPARATIONS
Organon & Co. (OGN) is listed on the New York Stock Exchange, where it has traded since May 14, 2021.
- Listed On
- the New York Stock Exchange
- Listed Since
- May 14, 2021
- Employees
- 10,000
- Market Cap
- $3.6B
About Organon & Co.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 618 institutions reported holding OGN, with 218.2 million shares worth $2.9 billion in aggregate. The largest reported holder was BlackRock, with 32.1 million shares worth $434.0 million. Of the 5 largest holders listed below, 1 opened a new position in OGN, 2 added shares and 2 reduced their positions during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| BlackRock | 32,056,866 | $434M | Added 1.07% |
| Vanguard | 29,172,358 | $395M | Reduced 18.53% |
| Pentwater Capital Management | 18,100,000 | $245M | New position |
| State Street | 9,659,371 | $131M | Reduced 2.99% |
| UBS Group | 5,598,538 | $76M | Added 31.72% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is OGN?
Organon & Co. (OGN) is listed on the New York Stock Exchange, where it has traded since May 14, 2021.
Who are the largest institutional holders of OGN?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of OGN were BlackRock, Vanguard and Pentwater Capital Management.
How many institutions own OGN?
618 institutions reported a position in OGN for the quarter ended June 30, 2026, worth $2.9 billion in total.
Did institutions buy or sell OGN last quarter?
Of the 5 largest reported holders, 1 opened a new position in OGN, 2 added shares and 2 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for OGN.
Every reported institutional holder, plus insider and congressional trades in OGN, on SentiSense.